Figure S5. Reprogramming efficiency after ETO or PC treatment in different stages. (a) Relative levels of alkaline phosphatase (AP)-positive colonies with or without perhexiline maleate sodium (PMS; 2 μg/ml) after reprogramming in the presence of palmitoylcarnitine (PC; 25 μM). (b) FACS results of the percentage of GFP-positive cells in different stages with different treatments (PC 1–7 days, PC 1–14 days, PC 1–21 days, ETO 1–7 days, ETO + PC 1–7 days, and ETO + AC 1–7 days) after reprogramming. Data are presented as the mean ± SEM (n = 3). **P < 0.01; ***P < 0.005 (Student’s t test). (TIF 1080 kb
